| Erin Mclain Thomas, MA, LPC | |
|
1200 S College Ave Unit 310, Fort Collins, CO 80524-3764 | |
| (970) 672-5535 | |
| Not Available |
| Full Name | Erin Mclain Thomas |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 1200 S College Ave Unit 310, Fort Collins, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043562796 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | (* (Not Available)) | Secondary |
| 101YP2500X | Counselor - Professional | LPC-12106 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Erin Mclain Thomas, MA, LPC 1200 S College Ave, Suite 208, Fort Collins, CO 80524-3749 Ph: (970) 672-5535 | Erin Mclain Thomas, MA, LPC 1200 S College Ave Unit 310, Fort Collins, CO 80524-3764 Ph: (970) 672-5535 |
News Archive
The tiniest babies need special follow-up care when they go home from the hospital after birth. But, of the thousands of very-low-birth-weight babies born in California during 2010 and 2011, 20 percent were not referred to the state's high-risk infant follow-up program, according to a new study by researchers at the Stanford University School of Medicine.
Scientists from Russia and China discovered a host of new and unexpected nanoparticles and found a way to control their composition and properties the findings that break fresh ground in the use of nanoparticles.
The California Institute for Regenerative Medicine (CIRM) has awarded a $1.58 million grant to Huei-Sheng Vincent Chen, Ph.D., associate professor at Sanford-Burnham Medical Research Institute (Sanford-Burnham). Chen's proposal was one of 28 new projects funded as part of CIRM's Basic Biology IV awards program, which supports basic research aimed at increasing our understanding of stem cells and how to work with them.
Boehringer Ingelheim announced today that the US Food and Drug Administration (FDA) has approved a new indication for MICARDIS® (telmisartan) for the reduction of the risk of myocardial infarction (heart attack), stroke, or death from cardiovascular (CV) causes in patients 55 years of age or older at high risk of developing major CV events who are unable to take ACE inhibitors. MICARDIS® is the first treatment in its class to be approved for this indication.
› Verified 2 days ago
Craig Mcfadden, MA, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 4601 Corbett Dr, Fort Collins, CO 80528 Phone: 970-207-4800 Fax: 970-207-4805 | |
Caroline Catherine Bunn, LPC, MA Counselor Medicare: Not Enrolled in Medicare Practice Location: 4856 Innovation Dr Ste B, Fort Collins, CO 80525 Phone: 970-494-4200 | |
Velma G Gallegos, CAC III Counselor Medicare: Not Enrolled in Medicare Practice Location: 525 W Oak St, Fort Collins, CO 80521 Phone: 970-494-4300 | |
Mrs. Kayla Elizabeth Poulson, MA, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 425 W Mulberry St Ste 101, Fort Collins, CO 80521 Phone: 970-530-2887 | |
Monica Rowell, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 4115 Boardwalk Dr, Suite 100, Fort Collins, CO 80525 Phone: 970-493-4580 | |
Stephanie Robyn Saxe, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1525 Riverside Ave, Fort Collins, CO 80524 Phone: 651-967-2006 | |
Elizabeth Poulin-rodriguez, Counselor Medicare: Not Enrolled in Medicare Practice Location: 320 W Olive St, Fort Collins, CO 80521 Phone: 970-430-5425 |